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Abstract
We conducted a randomized controlled trial (RCT) of an early palliative care 
intervention (ENABLE: Educate, Nurture, Advise, Before Life Ends) for persons 
with advanced cancer and their family caregivers. Not all patient participants 
had a caregiver coparticipant; hence, we explored whether there were relation-
ships between patient survival, having an enrolled caregiver, and caregiver out-
comes prior to death. One hundred and twenty- three patient- caregiver dyads 
and 84 patients without a caregiver coparticipant participated in the ENABLE 
early versus delayed (12 weeks later) RCT. We collected caregiver quality- of- life 
(QOL), depression, and burden (objective, stress, and demand) measures every 
6 weeks for 24 weeks and every 3 months thereafter until the patient’s death 
or study completion. We conducted survival analyses using log- rank and Cox 
proportional hazards models. Patients with a caregiver coparticipant had sig-
nificantly shorter survival (Wald = 4.31, HR = 1.52, CI: 1.02–2.25, P = 0.04). 
After including caregiver status, marital status (married/unmarried), their 
 interaction, and relevant covariates, caregiver status (Wald = 6.25, HR = 2.62, 
CI: 1.23–5.59, P = 0.01), being married (Wald = 8.79, HR = 2.92, CI: 1.44–5.91, 
P = 0.003), and their interaction (Wald = 5.18, HR = 0.35, CI: 0.14–0.87, 
P = 0.02) were significant predictors of lower patient survival. Lower survival 
in patients with a caregiver was significantly related to higher caregiver demand 
burden (Wald = 4.87, CI: 1.01–1.20, P = 0.03) but not caregiver QOL, depres-
sion, and objective and stress burden. Advanced cancer patients with caregivers 
enrolled in a clinical trial had lower survival than patients without caregivers; 
however, this mortality risk was mostly attributable to higher survival by 
 unmarried patients without caregivers. Higher caregiver demand burden was 
also associated with decreased patient survival.
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Introduction
We conducted a fast track randomized controlled trial 
(RCT) with 207 newly diagnosed advanced cancer patients 
and 123 family caregivers to test the ENABLE III (Educate, 
Nurture, Advise, Before Life Ends) nurse- led, telephone- 
based palliative care intervention. This RCT demonstrated 
that concurrent palliative care initiated soon after a diag-
nosis of advanced cancer had beneficial effects on patient 
survival and caregiver depression and burden compared 
with initiating this intervention 12 weeks later [1, 2]. 
Because we enrolled patient participants with and without 
family caregivers, we had a “natural” experiment [3] allow-
ing us to examine whether the presence of a caregiver 
and a caregiver’s wellbeing and burden might also be 
related to patient survival.
Caregivers perform a plethora of health- related tasks 
that appear vital for advanced cancer patients’ survival. 
They spend an average of 8 h/day [4] tracking and 
treating symptoms; administering medications and 
breathing treatments; coordinating medical appoint-
ments; participating in advance care planning and other 
healthcare decision- making; providing emotional and 
spiritual support; preparing meals; managing finances; 
and performing domestic home duties [5–8]. Over time, 
however, caregivers may become burdened by perform-
ing these tasks.
Part of this burden relates to caregivers feeling untrained 
and unprepared [6, 8, 9], while other parts relate to wit-
nessing someone close to them struggle with serious illness. 
Thus, caregivers become prone to depression [10], anxiety 
[11], and poor physical health [12, 13]. As the Institute 
of Medicine [14] and others [15, 16] have reported, this 
poor caregiver health can attenuate a caregiver’s ability 
to provide care to cancer patients. This line of reasoning 
served as the impetus for us to include a parallel inter-
vention specifically for family caregivers in the ENABLE 
III trial. Nurse coaches provided one- on- one support and 
education to caregivers about caregiving tasks, and about 
how to cope with their care recipients’ struggle with seri-
ous illness. We believed this would improve caregivers’ 
wellbeing and performance thus benefiting cancer patients’ 
wellbeing and survival. Indeed, the main results of our 
trial demonstrated that caregivers had lower depressed 
mood and stress burden [2].
However, two unanswered questions remained: (1) What 
relationship exists between having a family caregiver and 
a patient’s survival? (2) What relationships exist between 
a caregiver’s outcomes (quality- of- life [QOL], depression, 
and burden) and a patient’s survival? To address these 
questions, we conducted a secondary analysis of our clini-
cal trial data. We hypothesized that having a caregiver 
would be associated with increased patient survival, and 
that higher caregiver QOL and lower caregiver depression 
and burden would be associated with increased patient 
survival.
Methods
This was a secondary analysis of the ENABLE III [1, 2] 
“fast track” RCT [17]. Individuals with newly diagnosed, 
recurrent, or progressive metastatic cancer and their car-
egivers (if they had one and were willing to enroll) were 
randomly assigned to receive the intervention as soon as 
possible after diagnosis (early group) or 12 weeks later 
(delayed group). The study protocol, data and safety 
monitoring plan were approved by the Norris Cotton 
Cancer Center/Dartmouth College and the Veterans 
Administration (VA) Medical Center, White River Junction, 
Vermont institutional review boards. The trial was 
 registered in clinicaltrials.gov (Identifier NCT01245621).
Sample and setting
Patient and caregiver participants in the ENABLE III trial 
were recruited between October 11, 2010 and March 5, 
2013 from the Norris Cotton Cancer Center at Dartmouth- 
Hitchcock Medical Center (DHMC), affiliated DHMC 
outreach clinics, and the White River Junction, Vermont 
VA Medical Center. Patient inclusion criteria were: (1) 
age >18 years; (2) within 30–60 days of being informed 
by a treating oncologist of a new diagnosis, recurrence, 
or progression of an advanced- stage cancer; (3) oncologist- 
estimated prognosis of 6–24 months; (4) English speaking; 
and (5) able to complete baseline questionnaires. Patients 
were excluded if: they scored <4 on the Callahan Cognitive 
Screen; [18] had an active Axis I psychiatric condition 
(e.g., schizophrenia, bipolar disorder) or substance use 
disorder; or had uncorrectable hearing disorder or unreli-
able telephone service. Patient participants were asked to 
nominate a family caregiver, defined as “a person who 
knows you well and is involved in your medical care” 
to participate in a parallel intervention. Patients were not 
excluded if they did not have a participating caregiver. 
There were no other caregiver eligibility criteria. After 
completing baseline measures, patients and their caregiver 
coparticipants, if they had one, were randomly assigned 
to receive early or delayed intervention.
The ENABLE III early palliative care 
intervention
The ENABLE III intervention was initially developed in 1998 
as a Robert Wood Johnson demonstration project to inte-
grate early palliative care with oncology care and has now 
been refined and evaluated in two large multisite RCTs [1, 
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2, 19–21]. Details of the intervention are described elsewhere 
[1, 2, 20] and on the National Cancer Institute’s Research- 
tested Intervention Programs website (rtips.cancer.gov/rtips/
index.do). Briefly, the ENABLE III intervention consisted 
of: (1) an outpatient palliative care assessment following 
National Consensus Guidelines [22] (caregivers invited to 
attend); (2) a series of individualized phone sessions deliv-
ered weekly by nurse coaches following a guidebook called 
Charting Your Course (patients: 6 sessions; caregivers: 3 
sessions); and (3) monthly follow- up to reinforce previous 
content as needed or to address new issues. Patients and 
caregivers received their one- on- one sessions with a separate 
nurse coach. The first three patient and caregiver sessions 
addressed decision- making and problem- solving strategies 
(based upon the principles of Problem- solving Treatment 
and the COPE program) [23–26], communication skills, 
advance care planning, and symptom management. The 
patient portion of ENABLE III included three more sessions 
that incorporated the Outlook life review intervention devel-
oped by Steinhauser and colleagues [27, 28].
Data collection and measures
Caregiver outcome measures were collected by telephone 
by a study coordinator blinded to group assignment at 
baseline and every 6 weeks for 24 weeks and then every 
12 weeks until the patient’s death or study completion. 
Caregiver QOL was measured using the 35- item Caregiver 
QOL- Cancer Scale (CQOL- C) (score range 0–140: higher 
scores = worse QOL) [29]. Domains of the CQOL- C 
include physical, emotional, and spiritual wellbeing related 
to caregiving and relationship quality with the care recipi-
ent. Internal consistency has been reported as 0.91 and 
a test–retest reliability as 0.95. Caregiver depressed mood 
was measured using the 20- item Center for Epidemiological 
Studies Depression (CES- D) scale (score range 0–60; higher 
scores = higher depressed mood; >16 = clinically signifi-
cant depression) [30, 31]. Caregiver burden was measured 
using the 14- item Montgomery Borgatta Caregiver Burden 
Scale (MBCB) that includes objective, demand, and stress 
burden subscales (subscales α = 0.88, 0.74 and 0.84, 
respectively) [32, 33]. Objective burden is defined as 
interference with the caregiver’s private, social and rec-
reational time, and normal daily routine (e.g., restrictions 
on vacations and trips, amount of time for friends, amount 
of personal privacy). Demand burden is defined as the 
degree of strain on caregivers due to feeling that their 
care recipients are overly demanding (e.g., attempts by 
care recipient to manipulate caregiver, unreasonable care 
recipient demands and requests). Stress burden is defined 
as the emotional strain felt by caregivers due to caregiving 
tasks (e.g., life tension, anxiety, depression about the care 
recipient relationship).
Statistical methods
t- Tests and Pearson’s chi- square were used to examine 
demographic and baseline patient outcome differences 
between patients with and patients without a caregiver. 
Variables with significant differences between groups were 
included as covariates in survival analyses (i.e., variables 
significantly associated with having a family caregiver). 
Cox proportional hazards regression analyses [34] were 
used to model: (1) the association between caregiver 
coparticipant presence/absence and survival (with and 
without adjustment for baseline covariates) and (2) the 
association between caregivers’ QOL, depressed mood, and 
burden (objective, demand, and stress burden) measured 
both at baseline and at the last occasion before patients’ 
death and patient survival. Patients with missing covariate 
data were excluded as needed for each Cox model.
Results
Table 1 lists caregiver demographic characteristics. The 
mean age was 59.4 years. Most caregivers were female 
(78.0%, n = 96); White race (92.7%, n = 114); Protestant 
(33.3%, n = 41); married or living with a partner (91.9%, 
n = 113); employed full or part time (49.6%, n = 61); 
and were the patient’s spouse/partner (75.6%, n = 93). 
The diagnoses of the care recipients were lung (43.1%, 
n = 53), gastrointestinal (25.2%, n = 31), genitourinary 
(8.1%, n = 10), breast (8.1%, n = 10), hematologic (5.7%, 
n = 7), and other solid tumor cancers (10.6%, n = 13).
Table 2 lists patient characteristics and compares groups 
of patients with (n = 123) and without caregivers (n = 84). 
Compared to patients without caregivers, patients with 
caregivers were older (62.4 vs. 65.7, P = 0.02); male (38.1% 
vs. 62.6%, P < 0.01); married or living with a partner 
(53.6% vs. 73.2%, P < 0.01); and were more likely to 
have a living will or durable power of attorney (34.5% 
vs. 49.6%, P = 0.05). There were no differences in patients’ 
other demographics, Charlson scores, Karnofsky 
Performance Status (KPS), symptom impact, depressed 
mood (CES- D), QOL (FACIT- Pal), clinical trial enroll-
ment, presence of a do- not- resuscitate (DNR) order, or 
intervention group.
Caregiver status and patient survival
In a Cox regression model that included the caregiver 
status predictor and no covariates, having a caregiver 
coparticipant was associated with reduced patient survival 
(n = 207, Wald(1) = 4.31, HR = 1.52, CI: 1.02–2.25, 
P = 0.04) (see Fig. 1). In a model that included covari-
ates correlating significantly with caregiver status (patient 
age, patient gender, marital status [married/unmarried], 
856 © 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. 
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and advance directive status [see Table 2]), caregiver status 
was not associated with reduced survival (n = 205, 
Wald(1) = 1.33, HR = 1.28, CI: 0.84–1.96, P = 0.25); 
however, marital status was significantly associated with 
reduced survival (n = 205, Wald(1) = 4.33, HR = 1.62, 
CI: 1.03–2.56, P = 0.04). Because caregiver status was 
significantly associated with marital status, we conducted 
a Cox regression analysis that included caregiver status, 
marital status, and their interaction as simultaneous pre-
dictors while covarying patient age, gender, and advance 
directive status. In this model, caregiver status (n = 205, 
Wald(1) = 6.25, HR = 2.62, CI: 1.23–5.59, P = 0.01), 
marital status (n = 205, Wald(1) = 8.79, HR = 2.92, CI: 
1.44–5.91, P = 0.003), and their interaction (n = 205, 
Wald(1) = 5.18, HR = 0.35, CI: 0.14–0.87, P = 0.02) 
were significant predictors of survival. The interaction 
took the form such that caregiver status was a significant 
predictor of survival among unmarried but not among 
married patients. Hence, when Cox analyses were con-
ducted separately, caregiver status was a significant predic-
tor of reduced survival among unmarried patients 
(Wald = 5.19, HR = 2.44, CI: 1.13–5.25, P = 0.02), but 
not among married patients (Wald = 0.37, HR = 0.86, 
CI: 0.52–1.42, P = 0.55). In order to illustrate this effect, 
a fourfold categorical variable was created (caregiver pre-
sent/married, caregiver present/unmarried, caregiver 
absent/married, caregiver absent/unmarried). When this 
variable was entered in a Cox regression model covarying 
patient age, gender, and advance directive status, it was 
a significant predictor of patient survival (Wald = 8.79, 
P = 0.02). Kaplan–Meier survival curves were generated 
for these four groups (see Fig. 2). Unmarried patients 
without a caregiver (indicated by the solid blue line) 
experienced better survival than the other three groups.
Caregiver QOL, depressed mood, and burden 
and patient survival
At baseline, caregiver QOL, depressed mood, and burden 
were not predictive of patient survival. At the last meas-
urement period before death, only caregiver demand burden 
(n = 77, Wald(1) = 4.87, CI: 1.01–1.20, P = 0.03) (Fig. 3) 
was significantly related to decreased survival. Caregiver 
QOL (n = 93, Wald(1) = 1.14, CI: 0.99–1.02, P = 0.29), 
depressed mood (n = 93, Wald(1) = 1.22, CI: 0.99–1.04, 
P = 0.27), objective (n = 81, Wald(1) = 1.68, CI: 0.97–1.15, 
P = 0.20) and stress burden (n = 91, Wald(1) = 1.77, 
CI: 0.97–1.16, P = 0.18) were not significant.
Post Hoc analysis
In our RCT, we collected two measures of a patients’ 
social support that could be related to having a caregiver: 
the Multidimensional Scale of Perceived Social Support 
[35] and the Social Well- being subscale of the FACIT- Pal 
[36]. Although both measures were related to caregiver 
status such that patients with caregivers had higher ratings 
of social support, neither measure was associated with 
patient survival (both with and without covariates). When 
these social support measures were included as covariates 










White people 114 92.7
Other 5 4.1
Missing/no response 4 3.3
Marital Status
Married or living with partner 113 91.9
Never Married 4 3.3
Divorced or separated 3 2.4
Widowed 2 1.6
Missing/no response 1 .8
Education
High school or GED; some college or 
technical school
70 56.9
≥ College graduate 51 41.5
<High school graduate 1 .8
Missing/no response 1 .8
Employment status
Full or part time 61 49.6
Retired 35 28.5
Not employed 25 20.3











Son or daughter 14 11.4
Parent 7 5.7
Other 1 .8
Missing/no response 1 .8






Other solid tumor 13 10.6
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Table 2. Patient characteristics.
Characteristic
All patients (N = 207) Patients with a caregiver (N = 123) Patients without a caregiver (N = 84)
P1No. % No. % No. %
Age, years
Mean 64.3 62.4 62.4 0.02
SD 9.9 9.9 9.9
Male gender 109 52.7 77 62.6 32 38.1 <0.01
Marital Status
Married 135 65.2 90 73.2 45 53.6 <0.01
Not married 72 34.8 33 26.8 39 46.4
Education
<High school graduate 11 5.3 6 4.9 5 6.0 0.92
High school graduate 111 53.6 67 54.5 44 52.4
College graduate 85 41.1 50 40.7 35 41.7
Race
White people 200 96.6 118 96.7 82 97.6 0.31
Black people 1 .5 0 0 1 1.2
Other 5 2.4 4 3.3 1 1.2
Missing 1 .5 1 .01 0 0
Religion
Catholic 65 31.4 34 27.6 31 36.9 0.41
Protestant 63 30.4 42 34.1 21 25.0
Jewish 1 .5 1 .8 0 0
None 44 21.3 25 20.3 19 22.6
Other 28 13.5 16 13.0 12 14.3
Missing 6 2.9 5 4.1 1 1.2
Employment Status
Employed 49 23.7 27 22.0 22 26.2 0.56
Retired 99 47.8 61 49.6 38 45.2
Not Employed 58 28.0 35 28.5 23 27.4
Student 1 .5 0 0 1 1.2
Medical insurance
Medicare 104 50.2 64 52.0 40 48.2 0.47
Private/Commercial 71 34.3 42 34.1 29 34.9
Military 19 9.2 12 9.8 7 8.4
Medicaid 7 3.4 4 3.3 3 3.6
Uninsured 5 2.4 1 .8 4 4.8
Missing 1 .5 0 0 1 1.2
Ever smoked 145 70.1 87 70.7 58 69.0 0.80
Diagnosis
Lung 88 42.5 53 43.1 35 41.7 0.68
Gastrointestinal tract 50 24.2 31 25.2 19 22.6
Breast 23 11.1 10 8.1 13 15.5
Other solid tumor 20 9.7 12 10.6 8 9.5
Genitourinary tract 16 7.7 10 8.1 6 7.1
Hematologic malignancies 10 4.8 7 5.7 3 3.6
Charlson score 6.3 1.7 (SD) 6.2 1.6 (SD) 6.3 2.0 (SD) 0.65
Karnofsky Performance Status 81.0 10.3 (SD) 81.1 11.0 (SD) 80.8 9.3 (SD) 0.84
FACIT- Pal (Baseline) 126.2 21.3 126.6 19.7 (SD) 125.6 23.4 (SD) 0.75
CES- D (Baseline) 14.2 10.1 13.3 8.8 (SD) 15.5 11.6 (SD) 0.14
QUAL- E, Symptom Impact 
Subscale (Baseline)
11.7 3.7 (SD) 11.6 3.7 (SD) 11.8 3.6 (SD) 0.61
In a clinical trial at enrollment 27 13.0 16 13.0 11 13.1 0.71
Advance directive in chart at enrollment
Living will or durable power 
of attorney 89 43.0 60 49.6 29 34.5 0.05
DNR order 20 9.7 13 11.7 7 8.5 0.63
Early intervention group 104 50.2 61 51.2 42 49.4 0.95
1Fisher’s exact or Pearson’s chi- square test for categorical variables and t- test for continuous variables. DNR, do- not- resuscitate.
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along with gender, age, and advance directive status, the 
results for caregiver and marital status remained essentially 
unchanged as shown in these results: caregiver status 
(n = 203, Wald(1) = 6.90, HR = 2.89, CI: 1.31–6.40, 
P = 0.009), marital status (n = 203, Wald(1) = 9.10, 
HR = 3.11, CI: 1.49–6.49, P = 0.003), and their 
interaction (n = 203, Wald(1) = 5.62, HR = 0.33, CI: 
0.13–0.83, P = 0.02).
Comment
We conducted a secondary analysis of the ENABLE III 
RCT data to examine whether advanced cancer patients’ 
higher survival would be associated with having a family 
caregiver, higher caregiver quality- of- life (QOL), and lower 
caregiver depression. Contrary to our hypothesis, patients 
with a caregiver coparticipant had lower survival compared 
to those without. This finding was mostly attributable to 
the higher survival of unmarried patients without caregiver 
coparticipants. Of interest, higher caregiver demand burden 
was associated with lower survival, while caregiver QOL, 
depression, objective burden, and stress burden were not. 
This is the first study to show a significant relationship 
between the survival of advanced cancer patients and 
family caregivers’ presence and burden.
It is unclear why patients with a caregiver had shorter 
survival compared with those patients in the trial who 
did not. We offer two possible explanations. First, patients 
who had a high- disease burden might have had more 
daily health needs that required the presence and assistance 
of a family caregiver. This high- disease burden might itself 
be associated with shorter survival; hence having a car-
egiver might represent sicker patients with a poorer prog-
nosis. However, the available data we collected of potential 
markers of disease severity did not support this explana-
tion. We found no detectable differences between those 
Figure 1. Patient survival curves by caregiver coparticipant presence/
absence. Cox proportional hazards model with no covariates.
Figure 2. Adjusted survival curves by caregiver and marital status. Cox 
proportional hazards model adjusted for patient age, gender, and 
presence of an advance directive and/or durable power of attorney.
Figure 3. Adjusted survival curves by high and low caregiver burden 
using median split. Cox proportional hazards model adjusted for 
intervention group.
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with and without a caregiver in baseline cancer diagnoses, 
Charlson scores, KPS scores, symptom impact, depressed 
mood, QOL, or clinical trial enrollment (see Table 2). It 
could be that there are other markers of disease severity 
that would better predict patient survival and needing a 
family caregiver. Thus, we recommend that this be explored 
in future studies.
A second potential explanation for our results could 
relate to patients’ self- perceived burden on their family 
caregivers [37–40]. When debilitating illnesses, such as 
cancer, constrain a patients’ ability to care for themselves 
thereby necessitating assistance from family members, it 
is possible that these patients begin to see themselves as 
an undue burden on others. There is some evidence to 
suggest that this reluctance to burden others may result 
in depression [40] and impact one’s health behaviors 
and preferences for treatment. For example, a study by 
Lee and colleagues [38] of 326 patient- caregiver dyads 
with distant stage cancers found that both higher patient 
self- perceived burden and higher caregiver burden scores 
were associated with lower preferences for life- sustaining 
treatments. While evidence is lacking in our study to 
directly support the mechanism of a patient’s reluctance 
to burden others, it is notable that compared to patients 
without caregivers, a higher proportion of patients with 
caregivers had a living will or durable power of attorney 
(see Table 2).
When conducting these analyses, we found it puzzling 
that just over half of the patient samples with no caregiver 
coparticipants were married (54%). This appears to chal-
lenge the adequacy of caregiver coparticipation as a proxy 
variable for caregiver status since it is reasonable to assume 
that these married patients may have been receiving some 
kind of assistance from their spouse. To clarify this puz-
zle, we included marital status in the Cox regression 
analysis as a predictor in the 4- group Kaplan–Meier curves 
(Fig. 2). This analysis revealed two important insights. 
First, being married was highly associated with having a 
caregiver coparticipant (Table 2). Second, the addition of 
marital status along with caregiver status as predictor 
variables in the Cox regression showed that the significant 
association with survival was maintained in the same 
negative direction, such that having a spouse was also 
associated with lower survival. This is consistent with the 
4- group Kaplan–Meier curves demonstrating that those 
patients who were unmarried with no caregiver copar-
ticipant had the better survival in comparison to everyone 
else who was either married and/or had a caregiver copar-
ticipant. Our interpretation of this is that those 54% of 
married patients with no caregiver coparticipant did in 
reality have a spouse who may have been providing sup-
port, however, this continued to be associated with 
decreased survival.
We propose several explanations for these findings. First, 
while numerous studies report a protective effect of mar-
riage on cancer mortality [41–47], other studies find mar-
riage associated with lower survival [48] (which is consistent 
with our findings). Alternatively, the relationship may vary 
depending on the history of a person’s marital status: for 
example, in a meta- analysis of the association of social 
networks with cancer mortality [49], survival was lowest 
for individuals who were never married compared to 
individuals who were divorced, separated or widowed. In 
our analyses, marital status was operationalized as mar-
ried/unmarried and hence it is likely that our unmarried 
patient group reflects a sample that is heterogeneous with 
regard to marital status history, making it difficult to 
interpret how marital status drives the findings.
Second, despite controlling for gender in our analyses, 
unmeasured factors associated with gender may explain 
our strong study results. Lending support for this hypoth-
esis, a meta- analysis of 1,365 nonsmall cell lung cancer 
patients by Siddiqui and colleagues [50] found that unmar-
ried females had higher overall survival than both married 
and unmarried males. This is especially compelling given 
that in our study, patients without a caregiver were largely 
unmarried and female.
Finally, our measure of marital status does not neces-
sarily indicate the quality of patients’ relationships and 
social support networks. A substantial body of literature 
has shown that the quality of relationships and social 
support have a significant impact on patients’ health and 
survival [51, 52]. In post hoc analyses, social support did 
correlate with having a caregiver coparticipant. However, 
neither the MSPSS nor the FACIT- Pal social well- being 
subscale was related to patient survival. Furthermore, 
inclusion of these social support measures did not change 
the results of the final model. This suggests that while 
the constructs of “social support” and “family caregiver” 
have related features, there are dimensions of having a 
family caregiver not related to social support that are 
associated with patient survival. Future research should 
examine how different types of social support, including 
the unique type of social support delivered by family 
caregivers, influence patients’ health and longevity.
For patients with a family caregiver, lower survival was 
associated with higher caregiver demand burden. That is, 
the patients of caregivers who perceived care recipients 
and their care to be overly demanding had a higher risk 
of death. Mirroring the first explanation above, patients 
with more severe and progressive life- limiting illness may 
have a greater need for assistance from caregivers that 
would impact a caregiver’s normal daily routine and sense 
of a patient’s overly demanding situation; however, we 
found no differences in these patients’ markers of disease 
severity at baseline.
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While provocative, these findings are subject to several 
limitations. First, this was not a prospective, planned 
analysis. Second, as is common across studies of the seri-
ously ill, we experienced significant caregiver attrition 
(32%) that could have resulted in a selection bias. It is 
reasonable to conjecture that those caregivers experiencing 
higher burden discontinued the study; however, as reported 
in the trial’s primary paper [2], we found no significant 
associations between attrition and caregiver demographics 
and outcomes. Third, this study included few caregivers 
and patients of a minority racial group, whose burden 
has been shown to differ from Whites [53], thus limiting 
generalizability. Fourth, it is not entirely known what 
proportion of patients who did not elect to have a car-
egiver participate did in fact have close family and friends 
who assisted them in some way with their care. In other 
words, patients with or without caregiver co- participants 
may not equate with actual caregivers available to patients. 
Future studies will benefit from having more detailed 
information about family support regardless of whether 
patients elect a caregiver to co- participate.
To conclude, we believe the results of this analysis are 
surprising relative to current literature and raise more 
questions than are answered. However, these findings are 
important as they serve to challenge our assumptions 
about the impact of family caregiving on patient outcomes. 
We echo what the Institute of Medicine [6, 54] and oth-
ers [16, 55] have recently emphasized, namely that there 
is a critical need to prioritize and place special emphasis 
on research and interventions aimed at better understand-
ing and supporting family caregiving for the critically ill 
and dying. The scope of this need is vast, as most of 
the over half million individuals with advanced cancer 
who are in their last year of life [56] have a family mem-
ber or close friend who assists them on a daily basis. 
Not only are these family caregivers encumbered with 
delivering nearly all of a patient’s daily care, they are 
burdened with witnessing someone close to them struggle 
with life- limiting illness. Hence, it is imperative that pal-
liative and oncology clinicians’ work together to ensure 
that these caregivers are supported in their role. 
Understanding how to best provide this support will be 
greatly benefited by continuing to improve our under-
standing of the complex dynamic between seriously ill 
patients and their family caregivers.
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